Daniel Gallacher

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

BMC medical informatics and decision making

Medical decision making : an international journal of the Society for Medical Decision Making

Clinical drug investigation

Health economics

University of Warwick

University of Leicester (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Warwick Oct 01 2018

United Kingdom

Research Fellow in Medical Statistics and Health Technology Assessment :: Warwick Evidence

University of Warwick Oct 01 2017 - Sep 30 2018

United Kingdom

Research Associate in Medical Statistics and Health Techonology Assessment :: Warwick Evidence

University of Warwick Oct 03 2016 - Sep 30 2017

United Kingdom

Research Associate (Statistician) :: Clinicial Trials Unit

Education History

University of Leicester Oct 01 2015 - Sep 13 2016

United Kingdom

MSC :: Health Sciences

University of Reading Sep 01 2011 - Aug 01 2014

United Kingdom

BSC

Publications

Daniel Gallacher
SurvInt: a simple tool to obtain precise parametric survival extrapolations. BMC medical informatics and decision making 24 (1) (2024)
Daniel Gallacher
SurvInt: a simple tool to obtain precise parametric survival extrapolations. BMC medical informatics and decision making 24 (1) (2024)
Daniel Gallacher
SurvInt: a simple tool to obtain precise parametric survival extrapolations. BMC medical informatics and decision making 24 (1) (2024)
Daniel Gallacher
SurvInt: a simple tool to obtain precise parametric survival extrapolations. BMC medical informatics and decision making 24 (1) (2024)
Carter Jemima, Joseph Chilcot, Daniel Gallacher, Yan-Shing Chang
Mode of birth and development of maternal postnatal post-traumatic stress disorder: A mixed-methods systematic review and meta-analysis. Birth (Berkeley, Calif.) 49 (4) (2022)
Daniel Gallacher, Nigel Stallard, Peter K Kimani, Elvan Gökalp, Juergen Branke
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicines. Health economics (2021)
Daniel Gallacher, Peter K Kimani, Nigel Stallard
Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations. PharmacoEconomics (2021)
Hannah Fraser, Daniel Gallacher, Felix Achana, Rachel Court, Sian Taylor-Phillips, Chidozie U Nduka, Chris Stinton, Rebecca Willans, Paramjit S Gill, Hema Mistry
Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation. Health technology assessment (Winchester, England) 24 (31) (2021)
Daniel Gallacher, Peter K Kimani, Nigel Stallard
Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study. Medical decision making : an international journal of the Society for Medical Decision Making 41 (4) (2021)
Felix Achana, Daniel Gallacher, Raymond Oppong, Sung Wook Kim, Stavros Petrou, James Mason, Michael Crowther
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data. Medical decision making : an international journal of the Society for Medical Decision Making 41 (6) (2021)
Rebecca Mottram, Wendy Lynn Knerr, Daniel Gallacher, Hannah Fraser, Lena Al-Khudairy, Abimbola A Ayorinde, Sian Williamson, Chidozie Nduka, Olalekan Abdulrahman Uthman, Samantha Johnson, Alexander Tsertsvadze, Christopher Stinton, Sian Taylor-Phillips, Aileen Clarke
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis. BMJ open 11 (11) (2021)
Christopher A Bannon, Daniel Gallacher, Petra Hanson, Harpal S Randeva, Martin O Weickert, Thomas M Barber
Systematic review and meta-analysis of the metabolic effects of modified-release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency. Clinical endocrinology 93 (6) (2020)
Daniel Gallacher, Peter Auguste, Pamela Royle, Hema Mistry, Xavier Armoiry
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer. Clinical drug investigation 39 (12) (2020)
Daniel Gallacher, Peter K Kimani, Nigel Stallard
Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study. Medical decision making : an international journal of the Society for Medical Decision Making 41 (1) (2020)
Daniel Gallacher, Peter Auguste, Martin Connock
How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017. International journal of technology assessment in health care 35 (2) (2019)

Daniel Gallacher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Gallacher